Search for Potential Non-Steroidal Inhibitors of 17 &bgr;-Hydroxysteroid Dehydrogenase (17 &bgr;-HSD) in the Treatment of Hormone-Dependent Cancers

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 3, 2007-04 ,pp. : 180-184

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17&bgr;-Hydroxysteroid Dehydrogenase

By  

Medicinal Chemistry, Vol. 2, Iss. 4, 2006-01 ,pp. : 329-347

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis, Biochemical Evaluation and Rationalisation of a Series of (3-O-Sulfonate) Derivatives of Estrone (E1) as Probes of the Active Site of Type 3 of the 17&bgr;-Hydroxysteroid Dehydrogenase (17&bgr;-HSD) Family of Enzymes

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 69-76

Bentham Science Publishers

Access to resources Recommend Favorite

Esters of Dehydroepiandrosterone (DHEA) as Probes for the Active Site of Type 3 17&bgr;-Hydroxysteroid Dehydrogenase (17&bgr;-HSD3)

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-06 ,pp. : 365-369

Bentham Science Publishers

Access to resources Recommend Favorite

Type 1 11 &bgr;-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite